UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.261

Sortiert nach

In Vitro Trials: The Dawn of a New Era for Drug Discovery in Atopic Dermatitis?

The Journal of pharmacology and experimental therapeutics, 2023-02, Vol.384 (2), p.245

2023

Link zum Volltext

Verfügbarkeit prüfen

H‐ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome

Clinical and experimental immunology, 2018-02, Vol.191 (2), p.220-228

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

Journal of internal medicine, 2015-08, Vol.278 (2), p.185-192

2015

Link zum Volltext

Verfügbarkeit prüfen

Endothelial‐to‐mesenchymal transition in systemic sclerosis

Clinical and experimental immunology, 2021-07, Vol.205 (1), p.12-27

2021

Link zum Volltext

Verfügbarkeit prüfen

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1[beta] via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Clinical and experimental immunology, 2015-10, Vol.182 (1), p.35

2015

Link zum Volltext

Verfügbarkeit prüfen

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in these patients

Clinical and experimental immunology, 2015-10, Vol.182 (1), p.35-44

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin‐36α axis is modulated in patients with primary Sjögren's syndrome

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.230-238

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-36[alpha] axis is modulated in patients with primary Sjögren's syndrome

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.230

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin (IL)-9/IL-9R axis drives gamma delta T cells activation in psoriatic arthritis patients

Clinical and experimental immunology, 2016-12, Vol.186 (3), p.277-283

2016

Link zum Volltext

Verfügbarkeit prüfen

Interplay of anti‐SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren’s syndrome

Journal of internal medicine, 2020-02, Vol.287 (2), p.214-215

2020

Link zum Volltext

Verfügbarkeit prüfen

Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study

Clinical and experimental immunology, 2016-06, Vol.184 (3), p.284-292

2016

Link zum Volltext

Verfügbarkeit prüfen

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

Lupus, 2015-03, Vol.24 (3), p.315-320

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin‐9 over‐expression and T helper 9 polarization in systemic sclerosis patients

Clinical and experimental immunology, 2017-11, Vol.190 (2), p.208-216

2017

Link zum Volltext

Verfügbarkeit prüfen

Interleukin (IL)‐9/IL‐9R axis drives γδ T cells activation in psoriatic arthritis patients

Clinical and experimental immunology, 2016-12, Vol.186 (3), p.277-283

2016

Link zum Volltext

Verfügbarkeit prüfen

The effect of laser surface textures on the corrosion resistance of epoxy coated steel exposed to aggressive environments for offshore applications

Surface & coatings technology, 2022-05, Vol.437, p.128371, Article 128371

2022

Link zum Volltext

Verfügbarkeit prüfen

Histopathology of salivary glands

Reumatismo, 2018-10, Vol.70 (3), p.146-154

2018

Link zum Volltext

Verfügbarkeit prüfen

H‐ferritin and CD68+/H‐ferritin+ monocytes/macrophages are increased in the skin of adult‐onset Still's disease patients and correlate with the multi‐visceral involvement of the disease

Clinical and experimental immunology, 2016-10, Vol.186 (1), p.30-38

2016

Link zum Volltext

Verfügbarkeit prüfen

Interleukin (IL)‐22 receptor 1 is over‐expressed in primary Sjogren's syndrome and Sjögren‐associated non‐Hodgkin lymphomas and is regulated by IL‐18

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.219-229

2015

Link zum Volltext

Verfügbarkeit prüfen

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

Annals of the rheumatic diseases, 2009-02, Vol.68 (2), p.163-168

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

Annals of the rheumatic diseases, 2011-10, Vol.70 (10), p.1788-1792

2011

Link zum Volltext

Verfügbarkeit prüfen

AB0328 What Could We Learn from The Sub-Analysis of A Single Nation Cohort in A Worldwide Study? Lesson from The Results Observed in The Italian Cohort of The GO-MORE Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1013-1013

2016

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular‐based therapy

Clinical and experimental immunology, 2013-08, Vol.173 (2), p.195-206

2013

Link zum Volltext

Verfügbarkeit prüfen

The CD68+/H‐ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H‐ferritin in the same tissue: correlation with disease severity and implication for pathogenesis

Clinical and experimental immunology, 2016-03, Vol.183 (3), p.397-404

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study

Spinal cord series and cases, 2020-08, Vol.6 (1), p.69-69, Article 69

2020

Link zum Volltext

Verfügbarkeit prüfen

Rituximab in primary Sjögren's syndrome: a ten-year journey

Lupus, 2014-11, Vol.23 (13), p.1337-1349

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.110)
Mit Volltextzugriff
(1.129)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Trials: The Dawn of a New Era for Drug Discovery in Atopic Dermatitis?

H‐ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome

Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

Endothelial‐to‐mesenchymal transition in systemic sclerosis

Interleukin‐36α axis is modulated in patients with primary Sjögren's syndrome

Interleukin-36[alpha] axis is modulated in patients with primary Sjögren's syndrome

Interleukin (IL)-9/IL-9R axis drives gamma delta T cells activation in psoriatic arthritis patients

Interplay of anti‐SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren’s syndrome

Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

Interleukin‐9 over‐expression and T helper 9 polarization in systemic sclerosis patients

Interleukin (IL)‐9/IL‐9R axis drives γδ T cells activation in psoriatic arthritis patients

The effect of laser surface textures on the corrosion resistance of epoxy coated steel exposed to aggressive environments for offshore applications

Histopathology of salivary glands

H‐ferritin and CD68+/H‐ferritin+ monocytes/macrophages are increased in the skin of adult‐onset Still's disease patients and correlate with the multi‐visceral involvement of the disease

Interleukin (IL)‐22 receptor 1 is over‐expressed in primary Sjogren's syndrome and Sjögren‐associated non‐Hodgkin lymphomas and is regulated by IL‐18

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

AB0328 What Could We Learn from The Sub-Analysis of A Single Nation Cohort in A Worldwide Study? Lesson from The Results Observed in The Italian Cohort of The GO-MORE Trial

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular‐based therapy

The CD68+/H‐ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H‐ferritin in the same tissue: correlation with disease severity and implication for pathogenesis

Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study

Rituximab in primary Sjögren's syndrome: a ten-year journey

Suchergebnisse filtern